罕见变异遗传学与扩张型心肌病严重程度:DCM精准医学研究
该研究分析了2016至2021年美国多中心DCM精准医学研究中1198例患者的临床与基因数据,按严重程度分为LVAD/HT组、仅ICD组和无ICD/LVAD/HT组。在校正社会人口学特征和合并症后,LVAD/HT组携带DCM相关致病或可能致病罕见变异的比值比是无ICD/LVAD/HT组的2.3倍(95%CI 1.5-3.6),且该关联不因 ancestry 而异;仅ICD组与无ICD/LVAD/HT组的罕见变异遗传发现相似。
要点
- 晚期DCM(需LVAD/HT)与致病/可能致病罕见变异独立相关,OR 2.3(95%CI 1.5-3.6)。
- 仅植入ICD的DCM患者与无ICD/LVAD/HT者的罕见变异遗传发现相似。
- 该关联在不同祖先背景间无差异,提示遗传风险分层可能广泛适用。
核心结论
- 晚期DCM与DCM相关致病或可能致病罕见变异的高比值比相关,相比严重程度较低的DCM患者。
- 该发现可能有助于评估DCM患者及其高危家属的结局风险。
研究设计与样本
- 研究分析了2016至2021年美国多中心DCM精准医学研究入组患者的临床和基因序列数据,该队列具有地理多样性、多种族和多族裔特征。
- 临床评估包括标准化患者访谈和病历查询表;DCM严重程度分为3组:晚期疾病需LVAD/HT、仅植入ICD、无ICD或LVAD/HT。
- 对36个DCM基因的罕见变异进行分类为致病或可能致病或意义未明变异;采用广义logit连接的多项式模型评估粗校正和校正后关联。
- 校正的混杂因素包括人口学特征、生活方式因素、医疗可及性、DCM病程和合并症。
主要发现
- 患者平均(SD)年龄51.9(13.6)岁;42%为非洲祖先,56%为欧洲祖先,44%为女性。
- 1198例患者中,347例有LVAD/HT,511例有ICD,340例无LVAD/HT或ICD。
- LVAD/HT组、仅ICD组和无ICD/LVAD/HT组中致病或可能致病变异百分比分别为26.2%、15.9%和15.0%。
- 校正社会人口学特征和合并症后,LVAD/HT组相比无LVAD/HT或ICD组携带DCM相关致病或可能致病罕见变异的比值比为2.3(95%CI 1.5-3.6)。
- 该关联不因祖先背景而异;仅ICD组与无ICD/LVAD/HT组之间的罕见变异遗传发现相似。
临床怎么用
- 对于DCM患者,检出DCM相关致病或可能致病罕见变异可能提示更高的晚期疾病(需LVAD/HT)风险。
- 遗传检测结果或可辅助DCM患者及其高危家属的结局风险评估与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dilated cardiomyopathy (DCM) can lead to advanced disease, defined herein as necessitating a durable left ventricular assist device or a heart transplant (LVAD/HT). DCM is known to have a genetic basis, but the association of rare variant genetics with advanced DCM has not been studied. METHODS: We analyzed clinical and genetic sequence data from patients enrolled between 2016 and 2021 in the US multisite DCM Precision Medicine Study, which was a geographically diverse, multiracial, multiethnic cohort. Clinical evaluation included standardized patient interview and medical record query forms. DCM severity was classified into 3 groups: patients with advanced disease with LVAD/HT; patients with an implantable cardioverter defibrillator (ICD) only; or patients with no ICD or LVAD/HT. Rare variants in 36 DCM genes were classified as pathogenic or likely pathogenic or variants of uncertain significance. Confounding factors we considered included demographic characteristics, lifestyle factors, access to care, DCM duration, and comorbidities. Crude and adjusted associations between DCM severity and rare variant genetic findings were assessed using multinomial models with generalized logit link. RESULTS: Patients' mean (SD) age was 51.9 (13.6) years; 42% were of African ancestry, 56% were of European ancestry, and 44% were female. Of 1198 patients, 347 had LVAD/HT, 511 had an ICD, and 340 had no LVAD/HT or ICD. The percentage of patients with pathogenic or likely pathogenic variants was 26.2%, 15.9%, and 15.0% for those with LVAD/HT, ICD only, or neither, respectively. After controlling for sociodemographic characteristics and comorbidities, patients with DCM with LVAD/HT were more likely than those without LVAD/HT or ICD to have DCM-related pathogenic or likely pathogenic rare variants (odds ratio, 2.3 [95% CI, 1.5-3.6]). The association did not differ by ancestry. Rare variant genetic findings were similar between patients with DCM with an ICD and those without LVAD/HT or ICD. CONCLUSIONS: Advanced DCM was associated with higher odds of rare variants in DCM genes adjudicated as pathogenic or likely pathogenic, compared with individuals with less severe DCM. This finding may help assess the risk of outcomes in management of patients with DCM and their at-risk family members. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03037632.
引用
- Hofmeyer M, Haas GJ, Jordan E, et al. Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study. Circulation. 2023. PMID: 37641966. doi:10.1161/CIRCULATIONAHA.123.064847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。